tiprankstipranks
Ajanta Pharma Limited (IN:AJANTPHARM)
:AJANTPHARM
India Market

Ajanta Pharma Limited (AJANTPHARM) Financial Statements

Compare
3 Followers

Ajanta Pharma Limited Financial Overview

Ajanta Pharma Limited's market cap is currently ₹325.68B. The company's EPS TTM is ₹71.613; its P/E ratio is 36.41; and it has a dividend yield of 1.36%. Ajanta Pharma Limited is scheduled to report earnings on January 30, 2025, and the estimated EPS forecast is ₹22.00. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Mar 23Mar 22Mar 21Mar 20
Income Statement
Total Revenue₹ 42.09B₹ 37.43B₹ 32.84B₹ 28.47B₹ 25.62B
Gross Profit₹ 30.93B₹ 26.92B₹ 23.97B₹ 21.65B₹ 18.72B
Operating Income₹ 19.68B₹ 6.62B₹ 8.08B₹ 8.90B₹ 5.88B
EBITDA₹ 12.57B₹ 8.81B₹ 10.44B₹ 10.24B₹ 7.71B
Net Income₹ 8.16B₹ 5.88B₹ 7.13B₹ 6.54B₹ 4.68B
Balance Sheet
Cash & Short-Term Investments₹ 4.60B₹ 8.44B₹ 3.28B₹ 3.78B₹ 2.69B
Total Assets₹ 46.38B₹ 46.79B₹ 40.56B₹ 37.79B₹ 33.19B
Total Debt₹ 352.80M₹ 356.30M₹ 250.30M₹ 313.60M₹ 749.60M
Net Debt₹ -942.10M₹ -2.94B₹ -1.81B₹ -1.46B₹ -1.27B
Total Liabilities₹ 10.71B₹ 12.91B₹ 7.91B₹ 7.83B₹ 7.20B
Stockholders' Equity₹ 35.67B₹ 33.88B₹ 32.64B₹ 29.96B₹ 25.99B
Cash Flow
Free Cash Flow₹ 6.33B₹ 6.17B₹ 4.13B₹ 4.05B₹ 2.17B
Operating Cash Flow₹ 7.85B₹ 7.92B₹ 5.62B₹ 5.76B₹ 4.57B
Investing Cash Flow₹ 653.90M₹ -5.60B₹ -741.00M₹ -2.82B₹ -2.24B
Financing Cash Flow₹ -10.51B₹ -1.08B₹ -4.60B₹ -3.18B₹ -1.29B
Currency in INR

Ajanta Pharma Limited Earnings and Revenue History

Ajanta Pharma Limited Debt to Assets

Ajanta Pharma Limited Cash Flow

Ajanta Pharma Limited Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis